Locations and Appointments
- Medical Oncology
- Myeloproliferative Neoplasm
- Polycythemia Vera
- Essential Thrombocythemia
- Chronic Myeloid Leukemia
- Hematologic Malignancy
- Medical Oncology
Clinical & Academic Positions
- Attending Physician - NewYork-Presbyterian Hospital
- Professor of Medicine - Weill Cornell Medical College, Cornell University
Education & Training
- M.D., Cornell University Medical College, 1953
As a physician, I have dedicated my career to improving the lives of people with cancer and blood disorders, with a special focus on myeloproliferative neoplasms (MPNs), including chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and primary myelofibrosis. I take pride that I am thought of not only as a master clinician, but also as a clinical scientist. Surely, it is through both patient care and science that we will cure the diseases to which we have dedicated ourselves. I am so pleased to have spent nearly my entire medical career at Weill Cornell, an institution that has afforded me the opportunity to focus on both the humanistic and scientific aspects of medicine.
Richard T. Silver, MD, is Professor of Medicine at Weill Cornell Medical College and Attending Physician, The New York Presbyterian Hospital. He is also the Emeritus Director, Richard T. Silver Myeloproliferative Neoplasms Center, Weill Cornell Medical College. Dr. Silver graduated from Cornell University in 1950 (AB) and received his M.D. from Cornell in 1953. He completed his postgraduate training in internal medicine and hematology at the New York Hospital – Cornell Medical Center. He was a Clinical Associate, Leukemia Service, General Medicine Branch, National Cancer Institute, where he was mentored by future leaders in the field, which influenced his decision to participate in the development of modern clinical cancer chemotherapy. After completing his training, Dr. Silver was asked to help establish a Residency Training Program as a Visiting Fulbright Professor at the University of Bahia, Salvador, Brazil, an effort supported, in part, by the Rockefeller Foundation. This collaboration between Weill Cornell and the University of Bahia still exists. While in Brazil, he was able to journey to study the blood groups of the primitive Indians of the Upper Xingu River region, where he discovered a new blood subgroup. This led to fellowship in the world-renowned Explorers Club.
Dr. Silver is internationally recognized as one of the pioneers in clinical cancer chemotherapy and clinical and translational investigations in the myeloproliferative neoplasms and chronic myeloid leukemia. Among his many accomplishments in the field, he is particularly known for the broad clinical application of the interferons for treating these diseases. He is widely credited with developing the use of the bone marrow biopsy technique used throughout the world for the diagnosis of hematologic disorders.
Dr. Silver has written 319 peer-reviewed articles, 4 books, 20 chapters, and innumerable abstracts. He is routinely listed among the Best Doctors in New York. He has been the co-chair and convener of 11 International Congresses on Myeloproliferative Diseases, held since 2001. Dr. Silver has been invited to speak at many national and international meetings and consensus conferences and has held many distinguished visiting professorships. Among his honors for his scientific work have been the Catherine Pasmantier Award, the Timothy Gee Award of the Straus Leukemia Foundation, the Lifetime Achievement Award of the Cancer Research & Treatment Fund, and the Lifetime Achievement Award of the SASS Foundation for Medical Research. He has also received an Award from the Dean of Weill Cornell Medical College for "Lifetime of Academic Achievement, Dedication and Service," the Honorary Lifetime Achievement Awards from the Israeli Society of Hematology and the University of Texas MD Anderson Cancer Center, the Weill Cornell Alumni Association and the Myeloproliferative Neoplasms (MPN) Heroes Award. He has been past President of Weill Cornell Alumni Association; Editor of the Cornell Alumni Magazine for a decade, and has served for years as a Senior Advisor to the Weill Cornell Alumni Association. He is a Life Member of the Cornell University Council.
In 1967, Dr. Silver founded Cancer Research & Treatment Fund (CR&T), a nonprofit organization dedicated to funding research into new treatments leukemia and other forms of cancer. He currently serves as the organization’s Vice President and Medical Director.
The Richard T. Silver Distinguished Professor of Hematology and Oncology and the Richard T. Silver Myeloproliferative Neoplasms Center have been named in his honor at Weill Cornell Medicine to recognize his enduring commitment and contributions to the understanding and treatment of myeloproliferative neoplasms.
Insurance Plans Accepted
For relevant information regarding accepted insurances, please contact this provider directly.
Honors and Awards
Honors and Awards
- New York State Scholarship for Professional Study of Medicine, 1950-1953
- Visiting Fulbright Lecturer, University of Bahia School of Medicine, Brazil, 1958‑1959
- Big Pi Award for Outstanding Civic Achievement, 1975
- Cornell University Medical College Award of Appreciation, 1976
- New York State Society of Medical Oncologists and Hematologists Award of Appreciation for Service as President 1991-2000
- Richard T. Silver Distinguished Visiting Professorship,1998
- Pasmantier Award of the New York Cancer Society and Fund for Blood and Cancer Research for Outstanding Accomplishment and Distinguished Service to Clinical Medicine and Medical Oncology, June 1999
- Richard T. Silver Distinguished Professorship in Hematology & Medical Oncology at Weill Medical College of Cornell University, 2001
- Timothy Gee Award for Outstanding Clinician, Teacher, Mentor, Humanist presented by Sass & Strauss Foundation, May 19, 2001
- Lifetime achievement award for pioneering work in clinical hematology and as Founder and Medical Director of the Cancer Research & Treatment Fund (CR&T), 2008
- Distinguished Emeritus member, American Society of Hematology, 2010
- Lifetime of Academic Achievement, Dedication and Service to Weill Cornell Medical College (WCMC), 2011
- The Weill Cornell Medical College Alumni Association Special Achievement Award, 2012
- Lifetime Achievement Award, The SASS Foundation for Medical Research, Inc., 2012
- Lifetime Achievement Award in the field of Hematology, Israel Society of Hematology and Blood Transfusion and the University of Texas MD Anderson Cancer Center, 2013
- Dedication, Richard T. Silver, M.D. Myeloproliferative Neoplasm Center at Weill Cornell Medical College, New York, New York, Weill Cornell Medical College, 2014
- Myeloproliferative Neoplasms (MPN) Heroes Award, 56th American Society of Hematology Meeting and Exposition, San Francisco, California, 2014
- Levine Cancer Institute Outstanding Achievement Award, 4th Annual Levine Cancer Institute Hematology Symposium, Charlotte, NC, 2018
- European Leukemia Net Merit Award, XVI European Leukemia Net Symposium, Mannheim, Germany, 2019